Schonfeld Strategic Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
+600
New +$214K ﹤0.01% 1711
2025
Q1
Sell
-45,000
Closed -$11.7M 2185
2024
Q4
$11.7M Sell
45,000
-10,000
-18% -$2.97M 0.07% 266
2024
Q3
$17.7M Buy
+55,000
New +$18M 0.12% 167
2024
Q2
Sell
-30,000
Closed -$8.53M 2121
2024
Q1
$8.53M Buy
+30,000
New +$8.78M 0.06% 433

Other funds holding AMGN

Schonfeld Strategic Advisors's AMGN Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 36,625 shares — an estimated $13.1M sold.

Schonfeld Strategic Advisors first reported a position in AMGN in Q3 2016 and held it in 26 quarters. The position peaked at $32.1M in Q2 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 36,625 Amgen shares in Q1 2026, an estimated $13.1M.
  • Schonfeld Strategic Advisors first reported a position in Amgen in Q3 2016 and held it in 26 quarters.
  • Schonfeld Strategic Advisors's Amgen position peaked at $32.1M in Q2 2022.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.